Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injury
Open Access
- 11 March 2025
- journal article
- review article
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (6) , 2243-2260
Abstract
Drug-induced cholestasis is one of the major mechanisms implicated in drug-induced hepatotoxicity that poses a serious problem in terms of patient morbidity and mortality, healthcare system expenses and efficacy of newly developed drugs. Impaired bile acid homeostasis due to transporter alterations, hepatocellular injury or canalicular abnormalities is the most characteristic feature of cholestasis. Given the complexity of cholestasis and the different underlying mechanisms, new models and technologies that span a variety of biological processes are needed to accurately predict drugs’ cholestatic potential. This review outlines the main triggering mechanisms of drug-induced cholestasis and summarizes the currently available in vitro systems and techniques that attempt to forecast and provide mechanistic details of cholestasis caused by drugs.Keywords
Funding Information
- Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 by PID2022-136433OB –C22, CNS2022-135425)
- Ministerio de Universidades (FPU19/02240)
- Instituto de Salud Carlos III (PI21/00223)
- Universitat de València
This publication has 129 references indexed in Scilit:
- Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cellsBiopharmaceutics & Drug Disposition, 2022
- Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes2019
- Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium PerspectiveClinical Pharmacology & Therapeutics, 2018
- Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approachArchives of Toxicology, 2016
- A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studiesArchives of Toxicology, 2014
- Bile Formation and Secretion2013
- Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cellsHepatology, 2012
- Membrane Vesicle ABC Transporter Assays for Drug Safety AssessmentCurrent Protocols in Toxicology, 2012
- Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3Journal of Pharmaceutical Sciences, 2011
- Hepatobiliary transporters and drug‐induced cholestasis†Hepatology, 2006